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Abstract 
 
Purpose: To evaluate the physical activity patterns of diabetic adults by the type of 
treatment they received 
 
Method: The study used secondary data collected by the National Health and Nutrition 
Examination Survey (NHANES) from 2001 to 2006. NHANES is a continuous study 
which measures the health and nutritional status of non-institutionalized citizens in the 
United States. To be eligible for the study, participants had to be an adult 18 years or 
older who responded during the interview phase of the survey that they had diabetes. 
Participants with any missing data pertaining to the variables were excluded.  After 
exclusions, the final size of the study population was 957. The type of treatment was 
defined as: insulin only, oral antidiabetic medication only, or neither. Physical activity 
was defined according to the guidelines set forth by the American Diabetes Association. 
A logistic model was used to assess the association between the type of treatment and 
regular physical activity. All data analyses were performed using SAS 9.1. 
 
Results: Overall, only 28.2% of the study participants were involved in regular physical 
activity. With respect to the type of treatment they received, a majority of the 
participants (69.9%) took oral antidiabetic medication, while 23.1% used insulin. Only 
7.1% didn’t take antidiabetic medication or insulin. Most of the study participants were 
either overweight or obese (86.1%). In relation to diabetes treatment type, the frequency 
of taking oral antidiabetic medication among those who were diagnosed with diabetes 
when they were 40 years of age or older was greater (76.9%) than the frequency of 
insulin use (64.9%) . Among this segment of the population, 81.6% didn’t use insulin or 
oral antidiabetic medication. Study participants who had diabetes for five years or less 
were more likely to take oral antidiabetic medication only, with 47.7% taking oral 
antidiabetic medication compared to 33.2% taking insulin. The crude odds ratio for 
insulin treatment and physical activity was 0.72 (CI, 0.32-1.61) while the crude odds 
ratio for treatment consisting of oral antidiabetic medication and physical activity was 
0.61 (CI, 0.31-1.21). After adjusting for confounding, the odds of being physically active 
for patients on insulin treatment was 0.62 (CI, 0.28-1.39), and for those on oral 
antidiabetic medication the odds of being physically active was 0.53 (CI, 0.27-1.08), 
indicating that there was no statistical significance between either treatment group and 
physical activity participation. 
 
Conclusions: Although not statistically significant, the prevalence of regular physical 
activity was highest (37.3%) among diabetic individuals who used neither insulin nor 
oral antidiabetic medication to control their diabetes, while 26.7% of participants who 
used oral antidiabetic drugs and 30% of participants who used insulin exercised 
regularly. However, the failure to participate in physical activity is a common problem 
among all diabetics, irrespective of group distinctions. Thus, all diabetics should be 
encouraged to participate in physical activity to reduce future complications.
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Introduction 
 
Diabetes is becoming a serious health burden in the United States. Approximately, 
23.6 million people or 8% of the United States population have diabetes.1,2  About a 
quarter of this segment of the population, or 5.7 million, are unaware of their disease 
status.1,2 The estimated prevalence of individuals diagnosed with diabetes has 
escalated from 5.6 million in 1980 to 17.6 million in 2007.3 The increase in the 
prevalence of diabetes during  this  27-year period represents a 220% percent increase.   
Diabetes is more common in specific segments of the population.  Diabetes 
disproportionately affects certain minority populations. After adjusting for age, the 
prevalence of diabetes among adults 20 years or older is estimated to be 11.8% for 
blacks and 10.4% for Hispanics, compared to 6.6% for whites.1,2 Diabetes is more 
common among those who are 40 years of age or older.1,2 Most of the people living with 
diabetes have type 2 diabetes.1,2 The increases in type 2 diabetes and obesity have 
occurred concurrently. The rise in obesity within the population has contributed to the 
increase in the prevalence of type 2 diabetes. 4-8 Obesity results in insulin resistance, 
which can hasten the development of type 2 diabetes. 9-10 The likelihood that an 
individual has diabetes or develops diabetes is proportional to BMI. 5,7,11 Obesity is also 
associated with hypertension and high cholesterol, which are comorbidities that typically 
accompany diabetes.5,6,8 
The presence of diabetes in the population has contributed to rising costs, especially 
in the healthcare industry. The medical costs related to diabetes totaled $116 billion in 
2007.1 The medical expenses that persons with diabetes incurred during 2007 were 2.3 
times higher than that of persons without diabetes.1 
 
 
 
Persons with poorly-controlled diabetes can develop severe complications in the 
future. 1,12-14 Diabetics have a greater risk of developing and dying prematurely from 
cardiovascular disease, 1,15-16 with approximately 75% of all diabetic deaths due to 
cardiovascular disease.13 Compared to persons without diabetes, individuals with 
diabetes have a two to four times greater risk of developing a stroke, and the death rate 
from heart disease is two to four times higher among diabetics.1,17 Failure to control 
diabetes can result in blindness, kidney disease, nerve damage, and amputations.1  
Good glycemic control can prevent future diabetes complications.12-14 The 
American Diabetes Association (ADA) recommends that diabetics maintain a 
hemoglobin A1c level below 7% to have optimal glycemic control.14 Diabetic individuals 
can achieve good glucose control if they practice self-management or self-care 
behaviors.18-19 Self-management behaviors can include such activities as monitoring 
glucose levels and diet, exercising, performing foot examinations, and taking prescribed 
antidiabetic medications.18-19 
Previous studies have shown physical activity to be beneficial in diabetes 
prevention and management. 5,14-16, 20-25 Physical activity can reduce the incidence of 
diabetes among  groups who may or may not be at a greater risk of developing type 2 
diabetes.4, 20-21 Persons with impaired glucose tolerance were less likely to develop 
diabetes if they had achieved the goal of exercising more than four hours per week.5 
Overweight or obese participants who had high levels of physical activity had lower 
levels of plasma insulin than participants with normal BMI and low level of physical 
activity; however, the levels of fasting glucose and insulin resistance were comparable 
in both groups.6 
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Regular physical activity is an effective way to manage diabetes. Physical activity 
improves insulin sensitivity and glycemic control.10,14-16, 22,25-26 A meta-analysis of 14 
trials demonstrated that the mean HbA1c was 0.66% lower after interventions with an 
exercise component.26 Physical activity can assist diabetics in achieving their optimal 
weight  to manage their diabetes.27 
 Few if any studies have specifically explored the relationship between physical 
activity among diabetic individuals and the type of treatment they receive.  Using U.S. 
population-based data, Nwasuruba et al. found that insulin users were more likely to 
participate in all four self-care behaviors—glucose testing, physical activity, 
fruit/vegetable consumption, and foot examination--than non-insulin users; however, 
participation in all four self-care behaviors was considerably low.19 In contrast, a cross-
sectional study using population-based data discovered that those individuals using 
insulin were less likely to participate in any physical activity.25 The purpose of this study 
is to evaluate the physical activity patterns among diabetic individuals who take oral 
antidiabetic medication only, insulin only, or no medication to treat their diabetes. 
Specifically, the aim of this study is to explore whether diabetic participants who take 
either antidiabetic medication or insulin report different levels of participation in physical 
activity than those participants who take neither antidiabetic medication nor insulin to 
manage their diabetes. The secondary objective of this study is to determine whether 
physical activity varies by demographics (age, gender, and race), age at diagnosis, 
duration of diabetes, BMI, hypertension status, and cholesterol status. 
Methods 
 Data Source 
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  The study used secondary data collected during the 2001-2002, 2003-2004 and 
2005-2006 cycles of the National Health and Nutrition Examination Survey (NHANES).28 
NHANES is a continuous survey that measures the health and nutritional status of non-
institutionalized adults and children in the U.S. population.28 NHANES is sponsored by 
the National Center for Health Statistics (NCHS) of the Centers for Disease Control and 
Prevention (CDC). The survey consists of two parts: a household interview and an 
examination in a mobile examination center (MEC).28 Members of the study team 
administer interviews and physical examinations to gather health and nutritional data 
about survey participants. Trained, bilingual interviewers conduct interviews in the 
homes of all selected participants, but not all participants receive an examination.28 The 
sample of residents selected to participate in the survey is representative of non-
institutionalized adults and children in the United States. Persons who are 15 to 19 
years old, 60 years of age and older, African-Americans, and Mexican Americans are 
oversampled to provide more accurate estimates for these groups.28 
Study Sample 
 A total of 29,029 individuals participated during the survey years. Eligible 
participants were adults 18 years or older who reported that they had been diagnosed 
with diabetes at any time except during pregnancy. Children aged 17 years and 
younger, adults without diabetes, and individuals with any missing data were excluded 
from the study. Children aged 17 years and younger weren’t eligible for the study 
because of the high probability that their parents influenced physical activity patterns. 
The final sample had a total of 957 eligible participants. 
Independent Variable 
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 The determinant of interest in the study was the type of diabetic treatment that 
the participant received. The study focused on three types of treatment: insulin only, 
oral antidiabetic medication only, or neither. Participants were classified as taking oral 
antidiabetic medication only if they responded that they were taking antidiabetic pills to 
lower their blood sugar, but not currently taking insulin. Diabetic participants who used 
insulin responded that they were taking insulin to lower their blood sugar, but not 
currently taking antidiabetic pills. 
Dependent Variable 
The measured outcome was physical activity participation. Physical activity was 
defined based on the American Diabetes Association’s (ADA’s) recommendations for 
physical activity to improve glycemic control, help maintain weight, and reduce 
cardiovascular risks in the adult diabetic population. The ADA recommends that diabetic 
individuals participate in at least 150 minutes per week of moderate aerobic physical 
activity or 90 minutes per week of vigorous aerobic physical activity.23 The core 
questions used to determine physical activity were the following :  
1) over the past 30 days, have you walked or bicycled as part of getting to and from 
work, or school, or to do errands?,  
2) over the past 30 days, did you do any tasks in or around your home or yard for at 
least 10 minutes that required moderate or greater physical effort?,  
3) over the past 30 days, did you do any vigorous activities for at least 10 minutes 
that caused heavy sweating, or large increases in breathing or heart rate?, and  
 4) over the past 30 days, did you do moderate activities for at least 10 minutes that 
cause only light sweating or a slight to moderate increase in breathing or heart rate?. 
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Participants fulfilled the physical activity requirement set forth by the ADA if they 
answered yes to at least one of the core questions and satisfied one of the following 
conditions:  
1) walked or bicycled as part of getting to and from work, or school, or to do errands 
at least once a day, five times a week, or 20 times per month for at least 30 minutes 
during each episode, 
2) performed activities in or around the home or yard at least 20 times per month for 
at least 30 minutes during each episode,  
3) performed vigorous physical activities at least 12 times per month for at least 30 
minutes during each episode, or  
4) performed moderate physical activities at least 20 times per month for at least 30 
minutes during each episode.  
Participants who exercised not at all or not enough to satisfy recommendations were 
categorized into one group. 
Confounding Variables 
Potential confounding variables were age, race, gender, duration of disease, age of 
diagnosis, hypertension status, cholesterol status, and BMI. Age categories were 18-49 
years and 50 years and older. Race/ethnicity was defined by the following categories: 1) 
Hispanic, 2) Non-Hispanic White, 3) Non-Hispanic Black, and 4) Other (including 
multiracial).  The groups Mexican American and other Hispanic were merged to create 
the Hispanic category. Duration of disease was determined by subtracting age at 
diagnosis from age in years during screening. Duration of disease was stratified as five 
years or less and more than five years. Age of diagnosis was defined as: under 40 
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years of age and 40 years and older. Participants had hypertension and/or high 
cholesterol if they reported that they had been diagnosed with either condition during 
the interview. Participants were underweight/normal weight if their BMI were under 25, 
overweight if their BMI were 25-29, and obese if their BMI were 30 or greater.  
Statistical Analyses 
The frequencies and percentages of the general characteristics within the study 
population were calculated. The frequencies and percentages of the characteristics of 
the study population by diabetic treatment type were also calculated. Differences in 
treatment type across groups with respect to demographic and other characteristics of 
the study population were calculated using a chi-square statistic.  A logistic regression 
model was used to evaluate the association between the type of treatment and physical 
activity. If potential confounders were found to change the crude odds ratios by 10%, 
the confounding variables were adjusted for in the logistic regression model. All 
statistical analyses were performed using SAS 9.1. 
Results 
The frequencies and weighted percentages of the characteristics of the study 
participants are presented in Table 1. Approximately 73.6% of the study population 
were 50 years of age and older. There were slightly more women (51.0%) than men 
(49.0%) in the study population. A majority of the participants were white (65.1%), while 
15.6% and 12.2% were black and Hispanic respectively. About 86% of the participants 
were either overweight or obese. Approximately 74.4% of the study participants had 
been diagnosed with diabetes when they were 40 years of age or older. About 70% of 
the study population took oral antidiabetic drugs only to manage their diabetes, while 
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only 7.1% didn’t take any antidiabetic drugs or insulin to manage their diabetes. More 
than half had hypertension (66%) and high cholesterol (64%) as comorbidities. 
Approximately 28.2% of the study population participated in regular physical activity as 
specified by the ADA. 
The percentages of participants reporting regular physical activity by treatment 
group and total study population are shown in Figure 1. The percent of regular physical 
activity was highest among those participants who took neither insulin nor oral 
antidiabetic medication. About 37.3% of participants who took neither insulin nor oral 
antidiabetic medication participated in regular physical activity.  In comparison, about 
30% of participants who took insulin and 26.7% of participants who took oral 
antidiabetic drugs satisfied the requirements for regular physical activity. Overall, 28.2% 
of the total study population participated in regular physical activity. 
The frequencies and percentages of the demographic and other characteristics 
of the study population by the treatment type are shown in Table 2.  Across all three 
participant groups, gender representation was nearly equal with just under 50% for 
males and slightly over 50% for female. The prevalences of insulin use and oral 
antidiabetic medication use were similar in relation to hypertension, cholesterol status, 
and BMI. Just over 60% of participants taking insulin and those taking oral medication to 
treat diabetes reported having hypertension (63.4% and 65.8% respectively). Similarly, 
60.3% of participants on insulin and 65.8% of participants on oral medication had been 
diagnosed with high cholesterol. More than 50% of participants taking insulin and those 
taking oral medication to treat diabetes were obese. Oral antidiabetic medication use 
was more prevalent than insulin use among individuals who were 50 years and older. 
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Approximately 76.2% of study participants on oral antidiabetic medication were 50 years 
of age or older, while about 65.3% of study participants on insulin belonged to this age 
category.  
The differences among the treatment types across groups according to 
demographic and other characteristics are described in Table 3. There were significant 
differences in treatment type in regard to age of diagnosis and duration of diabetes, p-
value= 0.0129 and p-value=0.0004 respectively.  The percent of insulin use among 
participants who were diagnosed when they were younger than 40 years old was 31.7% 
compared to 20.1% for participants who were diagnosed when they were 40 years of 
age or older. This finding may be related to the fact that participants who are diagnosed 
with diabetes when they are younger than 40 years of age are maybe more likely to be 
diagnosed with type 1 diabetes, which requires insulin for treatment.  The percent of 
oral antidiabetic medication use was greater when the study participants had diabetes 
for five years or less (73.5%) than when they had diabetes for more than five years 
(66.8%). Among participants who had diabetes for more than five years, insulin use 
became more common, with 28.2% using insulin compared to 16.9% of those having 
diabetes for five years or less.   
Associations between the variables and regular physical activity are described in 
Table 4. The crude odds ratio for the association between treatment type and regular 
physical activity when the treatment was insulin only was 0.72 (CI, 0.32-1.61), while the 
association for oral antidiabetic medication was 0.61 (CI, 0.31-1.21). Participants who 
belonged to the racial/ethnic category of other were significantly more likely to 
participate in physical activity (OR=2.50; 1.31-4.76). Diabetic individuals who had the 
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comorbidity hypertension were significantly less likely to participate in regular physical 
activity (OR=0.54; CI, 0.37-0.77). Participants with high cholesterol were less likely to 
participate in regular physical activity; however, the finding wasn’t significant (OR=0.86; 
CI, 0.56-1.33).  Obese individuals were 48% less likely to participate in regular physical 
activity (OR=0.52; CI, 0.32-0.85). Although it was determined that none of the variables 
were confounding variables, the variables were included in the final logistic regression 
model to confirm that the variables weren’t confounders. After adjusting for all study 
variables, there was no statistically significant association between taking insulin and 
physical activity (OR= 0.62; CI, 0.28-1.39) or taking oral antidiabetic drugs and physical 
activity (OR= 0.53; CI, 0.27-1.08). In adjusted analyses hypertension remained 
significant with 40% lower odds of participating in regular physical activity (OR=0.60; CI, 
0.39-0.91) and the racial/ethnic category of other also remained significant (OR=2.25; 
CI, 1.27-3.99). 
Discussion 
It is relevant to identify segments of the diabetic population that are more susceptible 
to poor outcomes that can aggravate their disease or result in premature mortality. 
Diabetic individuals who don’t regularly participate in physical activity are at risk of 
developing complications or dying prematurely.15, 17, 26 This study explored whether 
physical activity patterns varied according to the type of treatment diabetics received to 
manage their diabetes. However, in this sample, we did not find significant differences 
in physical activity patterns in individuals who reported taking either insulin or oral 
antidiabetic medication compared to those not on medication.  After adjusting for all 
variables, the association between treatment type and physical activity wasn’t significant 
10 
 
 
 
 
with an odds ratio of 0.62 (CI, 0.28-1.39) for those individuals who took insulin and 0.53 
(CI, 0.27-1.08) for those who took oral antidiabetic medication.  
However, participants who reported having hypertension were significantly less likely 
to participate in physical activity in both crude and adjusted analyses. Even after 
adjusting for all the variables, participants who had hypertension in addition to diabetes 
were 40% less likely to participate in physical activity (OR=0.60; CI, 0.39-0.91). In 
addition, participants who belonged to the racial/ethnic group of other were 2.25 times 
more likely to participate in physical activity (OR=2.25; CI, 1.27-3.99). 
 Our results support other studies examining physical activity among diabetics. A 
study using data obtained from NHANES III found that participants who took insulin 
were more likely to report that they didn’t participate in any physical activity when 
compared to those who used diet or oral medication to treat their diabetes.25 Another 
study showed that diabetics taking insulin were 45% less likely to comply with physical 
exercise recommendations than those individuals who used oral antidiabetic medication 
or diet to manage their diabetes (OR=0.55; p-value=0.04).29 
Physical activity is essential in diabetes management. Unfortunately, physical 
activity is infrequent among diabetics.7,25 Typically, diabetics exercise less than the 
general population.6 Approximately 72% of the participants in the current study had little 
or no physical activity. The percentage of diabetic individuals not physically active in this 
study was comparable to findings in other studies that measured physical activity 
among the diabetic population. A cross-sectional study using data from the 2003 
Medical Expenditure Panel Survey found that 39% of the diabetic participants were 
physically active, while 58% of participants without diabetes were physically active.7 
11 
 
 
 
 
Another study reported that 38% of individuals with type 2 diabetes didn’t exercise 
adequately according to recommendations, and 31% didn’t participate in any physical 
activity.25  
In comparison to other diabetes self-management behaviors, diabetic individuals are 
less receptive to incorporating physical activity into their daily routine. Diabetics find 
great difficulty in changing long-term behaviors such as poor participation in physical 
activity.10 Gatt et. al. found that diabetics felt they possessed the greatest control in 
taking medication and the least control in performing physical activity and making 
dietary changes.30 They further suggested that diabetic individuals were more willing to 
perform self-management behaviors that required less personal investment and drastic 
changes to lifestyle.30 Diabetic individuals complied more readily with performing foot 
care and weighing regularly than participating in physical activity.29 Only 24.3% of the 
diabetic patients complied with physical activity recommendations.29 
Traditionally,  diabetes treatment has been provided in a stepwise fashion.12  Initially, 
the course of treatment is diet and exercise to manage diabetes.10,12 As diabetes 
advances, diet and exercise are usually supplemented with oral antidiabetic medication 
and/or insulin.10  When a physician adds insulin to a diabetic’s treatment regimen, the 
assumption is that diet, exercise, and antidiabetic medications have failed to reduce 
hemoglobin levels sufficiently.12 Insulin therapy is synonymous with failure with previous 
treatments and severity of the disease.10 
Some are advocating another approach to manage diabetes more effectively. They 
suggest that those recently diagnosed with type 2 diabetes should begin treatment with 
insulin immediately to prevent the occurrence of diabetes complications.12 A study of 
12 
 
 
 
 
subjects who had been recently diagnosed with type 2 diabetes discovered that 
individuals who started insulin soon after diagnosis had superior glycemic control and 
were more likely to avoid diabetes complications than individuals who followed the 
traditional, graduated pathway to manage their diabetes.12 However, diabetic patients 
who adhered to diet and exercise had better glycemic control.31  Thus, glycemic control 
in relation to diabetes management can’t be achieved solely by taking medication. The 
realization is that physical activity and diet work in concert with medication in diabetes 
management. Optimal glycemic control isn’t attainable if any of these hallmarks of 
diabetes management are absent.  
 A major strength of this study is the overall design of the survey. The method of 
sampling used by NHANES reduces selection bias, which allows for generalizability of 
the findings to the U.S. population. However, a few limitations are present in the study. 
The size of the study sample was relatively small compared to the NHANES total 
sample.  Only 957 participants were eligible for the study.  Due to the small sample size, 
the study may not have had the statistical power to detect a significant association 
between treatment type and physical activity. Another limitation is that physical activity 
survey items query only physical activity levels over the last 30 days, which may not be 
representative of patterns of activity over a longer period of time. In addition, physical 
activity is a self-reported measure. It may be difficult for most participants to accurately 
estimate the frequency and duration of physical activity in the past month. Because of 
this possibility, it is probable that some of the participants in the study were 
misclassified as participating in regular physical activity and vice versa. It is also likely 
that not all of the possible confounding variables were included in this study. Initially, 
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impaired functioning due to physical, mental, and emotional problems was considered 
as a possible confounding variable, but including this variable would have dramatically 
reduced the already minimal sample size. 
Conclusion 
Even if early insulin therapy is successful in improving outcomes for diabetics, the 
benefits of exercise shouldn’t be underestimated.  A study showed that individuals who 
were recently diagnosed with diabetes were more motivated to increase physical 
activity.32 The concern is that the shift to early insulin treatment may counteract against 
the benefits of exercise in managing diabetes. Diabetic patients who begin early insulin 
treatment may forgo physical activity because they deem insulin therapy to be the only 
way to manage their diabetes. Physical activity is infrequent among all diabetics, with 
only 28.2% of the study participants taking part in regular physical activity. Regardless 
of the treatment method employed, health professionals still need to continually 
emphasize the importance of physical activity in addition to adherence to treatment plan 
to their diabetic patients.  
14 
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Variable Unweighted  Weighted
N %
Age
 18-49 years 184 26.4
 50+ years 773 73.6
Sex
  Male 488 49.0
  Female 469 51.0
Race
  Hispanic 252 12.2
  Non-Hispanic White 402 65.1
  Non-Hispanic Black 260 15.6
  Other 43 7.1
Age of diagnosis
  Under 40 years 217 25.6
  40+ years 740 74.4
Duration of diabetes
  5 years or less 395 45.3
  Over 5 years 562 54.7
Hypertension
  Yes 584 66.0
  No 373 34.0
High Cholesterol
  Yes 584 64.0
  No 373 36.0
BMI
  Underweight/Normal Weight 153 13.9
  Overweight 313 31.0
  Obese 491 55.1
Treatment type
  Insulin only 225 23.1
  Oral antidiabetic drugs only 679 69.9
  Neither 53 7.1
Physical activity
  Yes 253 28.2
  No (little or no physical activity) 704 71.8
Figure 1 Percent of participants reporting regular physical activity by treatment 
group and total study population 
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Table 2 Frequencies and percent of participants' characteristics by treatment type 
Treatment type
Variable Oral antidiabetic
Weighted Weighted Weighted
N % N % N %
Age
 18-49 years 60 34.7 109 23.8 15 25.4
 50+ years 165 65.3 570 76.2 38 74.6
Sex
  Male 111 48.7 348 49.2 29 47.5
  Female 114 51.3 331 50.8 24 52.5
Race
  Hispanic 50 12.6 190 11.5 12 17.7
  Non-Hispanic White 95 64.0 280 65.1 27 68.6
  Non-Hispanic Black 69 17.8 177 15.1 14 13.7
  Other 11 5.6 32 8.3 0 0.0
Age of diagnosis
  Under 40 years 73 35.1 133 23.1 11 18.4
  40+  years 152 64.9 546 76.9 42 81.6
Duration of diabetes
  5 years or less 71 33.2 290 47.7 34 61.6
  Over 5 years 154 66.8 389 52.3 19 38.4
Hypertension
  Yes 143 63.4 467 65.8 38 76.2
  No 82 36.6 212 34.2 15 23.8
High Cholesterol
  Yes 130 60.3 423 65.8 31 58.7
  No 95 39.7 256 34.2 22 41.3
BMI
  Underweight/Normal Weight 42 17.6 99 12.3 12 18.4
  Overweight 71 29.8 227 31.0 15 34.8
  Obese 112 52.6 353 56.8 26 46.8
Physical Activity
  Yes 63 30.0 172 26.7 18 37.3
  No or little physical activity 162 70.0 507 73.3 35 62.7
n=225 n=679 n=53
Insulin 
only
Neither
drugs only
17 
Table 3 Differences among variable groups according to treatment type 
18 
Variable Oral antidiabetic p-value
n=679
N % N % N %
Age
 18-49 years 60 30.3 109 62.9 15 6.8 0.0580
 50+ years 165 20.5 570 72.3 38 7.2
Sex
  Male 111 23.0 348 70.2 29 6.9 0.9801
  Female 114 23.2 331 69.6 24 7.3
Race
  Hispanic 50 23.9 190 65.8 12 10.3 *
  Non-Hispanic White 95 22.7 280 69.9 27 7.5
  Non-Hispanic Black 69 26.2 177 67.6 14 6.2
  Other 11 18.3 32 81.7 0 0.0
Age of diagnosis
  Under 40 years 73 31.7 133 63.2 11 5.1 0.0129**
  40+  years 152 20.1 546 72.1 42 7.8
Duration of diabetes
  5 years or less 71 16.9 290 73.5 34 9.6 0.0004**
  Over 5 years 154 28.2 389 66.8 19 5.0
Hypertension
  Yes 143 22.1 467 69.7 38 8.2 0.3919
  No 82 24.8 212 70.2 15 4.9
High Cholesterol
  Yes 130 21.7 423 71.8 31 6.5 0.4043
  No 95 25.5 256 66.4 22 8.1
BMI
  Underweight/Normal Weight 42 29.2 99 61.5 12 9.4 0.3204
  Overweight 71 22.2 227 69.8 15 8.0
  Obese 112 22.0 353 72.0 26 6.0
*chi-square statistic couldn't be calculated due to insufficient number in one cell
**significant at p<0.05
Treatment type
Insulin 
only
n=225
drugs only
n=53
Neither
Table 4 Crude and adjusted odds ratios for physical activity in relation to study 
variables 
Variable OR CI OR CI
Age
  18-49 years 1.00 1.00
  50+ years 0.89 0.54-1.48 0.92 0.49-1.72
Sex
  Female 1.00 1.00
  Male 1.14 0.80-1.62 1.04 0.73-1.48
Race
  Non-Hispanic White 1.00 1.00
  Hispanic 1.14 0.60-2.17 0.95 0.50-1.83
  Non-Hispanic Black 0.74 0.47-1.18 0.77 0.51-1.17
  Other 2.50 1.31-4.76 2.25 1.27-3.99
Age of diagnosis
  Under 40 years 1.00 1.00
  40+  years 0.90 0.55-1.45 1.09 0.64-1.85
Duration of diabetes
  5 years or less 1.00 1.00
  Over 5 years 1.15 0.77-1.72 1.21 0.77-1.89
Hypertension
  Yes 0.54 0.37-0.77 0.60 0.39-0.91
  No 1.00 1.00
High Cholesterol
  Yes 0.86 0.56-1.33 0.97 0.64-1.48
  No 1.00 1.00
BMI
  Underweight/Normal Weight 1.00 1.00
  Overweight 0.84 0.50-1.40 1.05 0.63-1.72
  Obese 0.52 0.32-0.85 0.69 0.44-1.09
Treatment type
  Insulin only 0.72 0.32-1.61 0.62 0.28-1.39
  Oral antidiabetic drugs only 0.61 0.31-1.21 0.53 0.27-1.08
  Neither 1.00 1.00
*adjusted for all variables
Regular Physical Activity
Crude Adjusted
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